Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Domest Anim Endocrinol ; 74: 106579, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33161234

RESUMO

This study examined the effects of exogenous hCG administration on ovarian function and pregnancy rates in estrous-induced dairy goats during the transition into the breeding season. Eighty-six Toggenburg does received 60 mg of medroxyprogesterone acetate intravaginal sponge for 6 d plus 200 IU of equine chorionic gonadotropin and 30 µg of d-cloprostenol i.m. 24 h before sponge removal, and were then bred for 96 h. Seven days (D7) after first mating the does received either 1 mL of saline (the control group, n = 43) or 300 IU of hCG (the hCG-treated group, n = 43) i.m. Transrectal ovarian ultrasonography (B-mode and color Doppler) was performed on D7, D13, D17, and D21 and ultrasonographic pregnancy detection on D30. Pregnancy rate was higher (P < 0.05) in hCG-treated goats (90.7%; 39/43) than that in control animals (74.4%; 32/43). Accessory luteal structures (ALSs) were detected in 46.5% (20/43) of hCG-treated does. All hCG-treated does that had ALSs and 82.6% of goats without ALS post-treatment remained pregnant. The total luteal area increased (P < 0.05) from D7 to D13 in pregnant animals of both groups, whereas mean vascular area declined (P < 0.05) by D21 in all nonpregnant does. Serum progesterone concentrations increased (P < 0.05) on D21 in pregnant goats of both groups, but they were related to changes in luteal tissue content only in control does throughout the present study. Mean daily numbers of small- and medium-sized antral follicles decreased (P < 0.05) only in pregnant animals of both groups with a decline in medium follicle numbers occurring earlier in hCG-treated (D13) compared with control does (D17). To summarize, a single dose of hCG given on D7 after estrus was followed by a decrease in the number of medium-sized antral follicles in gestating hCG-treated does, induced the formation of ALSs in ~47% of all hCG-treated does, and significantly increased the pregnancy rate in estrous-induced Toggenburg goats in the transition to the breeding season.


Assuntos
Gonadotropina Coriônica/farmacologia , Cabras/fisiologia , Taxa de Gravidez , Substâncias para o Controle da Reprodução/farmacologia , Animais , Esquema de Medicação , Feminino , Humanos , Gravidez
2.
Anim Reprod Sci ; 209: 106172, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31514929

RESUMO

This study was conducted to evaluate effects of two administrations of d-cloprostenol at different intervals to synchronize the time of estrus and ovulation among estrous cyclic goats. In Experiment 1, 32 does were treated with 30 µg d-cloprostenol at 7.5 (T7.5, n = 16) or 11.5-day (T11.5, n = 16) intervals. In Experiment 2, the same treatments were administered and there was AI of the does (T7.5, n = 40 and T11.5, n = 38). In Experiment 1, ultrasonic assessments of ovaries were conducted at the time of the second administration of d-cloprostenol, every 12 h until detection of ovulation, and 7 days after estrous onset to detect the corpora lutea, as well as for pregnancy diagnosis 40 days after AI. In Experiment 1, the estrous response (90.6%, 29/32) was similar (P > 0.05) in both groups. Diameter of the largest follicle at the time of administration of the second dose was larger (P = 0.01) in the T7.5 than T11.5 group (7.0 compared with 5.7 mm), while the values for ovarian variables were similar (P > 0.05). In Experiment 2, the greatest (P < 0.001) synchrony in timing of initiation of estrus in does (T7.5 = 83.3% and T11.5 = 50.0%) occurred after the second day (36-48 h). The pregnancy rate tended (P = 0.0836) to be greater for does in the T7.5 (71.4%, 40/56) than T11.5 (55.6%, 30/54) group. With use of both protocols, there were acceptable estrous synchronization and pregnancy rates in estrous cyclic dairy goats.


Assuntos
Cloprostenol/administração & dosagem , Sincronização do Estro/métodos , Cabras , Inseminação Artificial , Taxa de Gravidez , Prenhez , Animais , Indústria de Laticínios , Esquema de Medicação/veterinária , Ciclo Estral/efeitos dos fármacos , Feminino , Inseminação Artificial/métodos , Inseminação Artificial/veterinária , Masculino , Ovulação/efeitos dos fármacos , Gravidez , Prenhez/efeitos dos fármacos , Fatores de Tempo
3.
Arq. bras. med. vet. zootec. (Online) ; 71(1): 345-348, jan.-fev. 2019. tab, graf
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1038586

RESUMO

Este estudo avaliou a eficiência de três protocolos de indução de estro síncronizado em ovelhas da raça Santa Inês. Vinte e quatro ovelhas adultas foram equitativamente distribuídas em três grupos, de acordo com ordem de parto, peso corporal (kg) e escore da condição corporal. As ovelhas receberam implante vaginal de progesterona natural por seis dias mais 37,5µg de d-cloprostenol laterovulvar e 300UI de eCG i.m., 24 horas antes da remoção do dispositivo. Ovelhas controle receberam CIDR330mg de progesterona, e as demais receberam dispositivo absorvente intravaginal humano, tamanho mini, embebido com 200 (OB200) ou 400mg (OB400) de progesterona. Coletas de sangue foram feitas nos momentos D0 (antes da inserção dos dispositivos), D0+6h e diariamente, até um dia após retirada do dispositivo (D7). A progesterona (ng/mL) foi semelhante (P>0,05) em todos os tratamentos ao longo do período experimental, exceto no dia da remoção do dispositivo, quando as ovelhas controle (2,5±0,3) tiveram progesterona superior (P<0,05) às ovelhas OB200 (0,6±0,1) e OB400 (1,2±0,4). O percentual de animais em estro (100,0, 62,5 e 100,0%) foi semelhante (P>0,05) e o intervalo para o estro (46,3±3,9a, 26,4±4,5b e 31,2±5,8a,b) foi diferente (P<0,05) entre os animais dos grupos controle, OB200 e OB400, respectivamente. A taxa de concepção das ovelhas foi de 50,0% (4/8) para cada grupo (P>0,05). Dispositivos humanos e fonte de progesterona podem ser usados para induzir o estro sincronizado em ovelhas Santa Inês.(AU)


Assuntos
Animais , Feminino , Progestinas/administração & dosagem , Progesterona/uso terapêutico , Administração Intravaginal , Ovinos , Sincronização do Estro/efeitos dos fármacos , Fertilidade
4.
Anim Reprod Sci ; 197: 203-211, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30177478

RESUMO

Hydrometra is characterized by the accumulation of fluid within the uterus due to the persistence of corpus luteum. The diagnosis of this disorder occurs with an ultrasonic exam. This study evaluated uterine drainage and fertility rates in goats after the use of d-cloprostenol in association or not with Gonadotropin-releasing hormone (GnRH) treatment. Twenty Saanen goats, diagnosed with hydrometra, received three 37.5-µg doses of d-cloprostenol laterovulvarly at 10-day intervals. On D5, the goats were assigned into two groups receiving 1 mL of GnRH or saline solution intramuscularly. Ultrasonography (US) was performed from D0 to D25. An US approach was used to rank hydrometra in scores. The pregnancy rate was assessed 45 and 90 days after the end of treatment. The uterine fluid was totally drained after the first and second administration of d-cloprostenol in 50% and 95% of the goats, respectively. In one female, full emptying of the uterus occurred only after D20. US performed at 45 and 90 days after the end of treatment indicated there was a pregnancy rate of 45.0% and 55.0%, respectively. Fertility did not differ between the GnRH-treated and control goats. Those goats not pregnant at 45 days had a follicular cyst, hydrosalpinx or hydrometra. At 90 days, no change was observed in the hydrosalpinx, and four goats had hydrometra. The use of three doses of d-cloprostenol 10 days apart was efficient for induction of draining the contents of the uterus, resulting in a relatively acceptable pregnancy rate. This treatment associated with the US approach can be important when applied in the field.


Assuntos
Cloprostenol/uso terapêutico , Doenças das Cabras/tratamento farmacológico , Ultrassonografia/veterinária , Doenças Uterinas/veterinária , Animais , Dinoprosta , Sincronização do Estro , Feminino , Doenças das Cabras/diagnóstico por imagem , Doenças das Cabras/fisiopatologia , Cabras , Hormônio Liberador de Gonadotropina , Inseminação Artificial , Gravidez , Taxa de Gravidez , Reprodução , Estações do Ano , Ultrassom , Ultrassonografia/métodos , Doenças Uterinas/diagnóstico por imagem , Doenças Uterinas/tratamento farmacológico , Doenças Uterinas/fisiopatologia
5.
Trop Anim Health Prod ; 50(4): 787-792, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29264820

RESUMO

In Brazil, great milk productivity was achieved after the implementation of a genetic improvement program. However, reproductive efficiency is still far from optimal, possibly due to the high number of undiagnosed disorders that may affect fertility. The aim of this study was to evaluate occurrences of the main reproductive disorders in dairy goats in southeastern Brazil. Data were collected between January 2015 and May 2017 from 23 commercial herds of different breeds, with goats ranging from 8 months to 12 years of age. Transrectal ultrasound exams were performed in 2680 goats. A total of 14.8% of the does showed a disorder in the reproductive tract: hydrometra (10.0%), ovarian follicular cysts (2.3%), gestational loss (1.5%), and hydrosalpinx (1.1%). This was the first study evaluating reproductive disorders in live animals that used a high number of Brazilian dairy goats. Considering that all these diseases affect fertility to different degrees, the performance of transrectal ultrasonography exams twice a year is strongly suggested, in order to guide precocious treatment or discard the animal as soon as possible, thus reducing economic losses in dairy goat farming.


Assuntos
Doenças dos Genitais Femininos/veterinária , Doenças das Cabras/diagnóstico por imagem , Ultrassonografia/veterinária , Animais , Brasil , Indústria de Laticínios , Feminino , Fertilidade , Doenças dos Genitais Femininos/diagnóstico por imagem , Cabras , Cistos Ovarianos/diagnóstico por imagem , Cistos Ovarianos/veterinária , Reprodução , Ultrassonografia/métodos , Doenças Uterinas/diagnóstico por imagem , Doenças Uterinas/veterinária
6.
Anim Reprod Sci ; 181: 16-23, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28385398

RESUMO

This study evaluated the efficiency of two d-cloprostenol injections at different intervals on the reproductive parameters of dairy goats. Trial 1 comprised 54 goats allocated to receive two 37.5µg d-cloprostenol doses at intervals of seven (T7, n=19), 10 (T10, n=18), and 11.5 (T11.5, n=17) days. Trial 2 comprised 62 goats allocated to receive injections at T7 (n=30) and T11.5 (n=32). Ultrasonography was done and blood was collected just before d-cloprostenol injections. After the second dose, goats were artificially inseminated (AI) with frozen-thawed semen at 18-24h (Trial 1) or at 10-24h (adjusted according to the time of estrus onset in Trial 2) after estrus detection. Estrus response rate did not differ (P>0.05) among groups in Trials 1 (T7=94.7%; T10=88.9%; T11.5=88.2%) and 2 (T7=90.0%; T11.5=96.9). All females showed progesterone concentrations >1ng/mL before both d-cloprostenol injections. The largest follicle diameter present on ovaries was similar (P>0.05) among treatments at the first and second dose. The second largest follicle diameter was superior (P<0.05) to T7 than to T10 and T11.5 goats at first dose only. This possibly resulted in lower interval to estrus (P<0.05) in T7-treated goats than other treated goats in both trials. The conception rate was similar among treatment groups in Trials 1 (T7=55.6%; T10=18.8%; T11.5=26.7%) and 2 (T7=85.2%; T11.5=93.6%). The three treatments efficiently synchronized estrus. T7 and T11.5 protocols resulted in high estrus synchrony and conception rates when adjusting the AI time according to interval of estrus.


Assuntos
Cloprostenol/farmacologia , Ciclo Estral/efeitos dos fármacos , Fertilidade/efeitos dos fármacos , Cabras/fisiologia , Luteolíticos/farmacologia , Animais , Cloprostenol/administração & dosagem , Esquema de Medicação , Sincronização do Estro/métodos , Feminino , Inseminação Artificial/veterinária , Luteolíticos/administração & dosagem , Gravidez
7.
Artigo em Inglês | MEDLINE | ID: mdl-26113381

RESUMO

In this review we show that the cephalopod vertical lobe (VL) provides a good system for assessing the level of evolutionary convergence of the function and organization of neuronal circuitry for mediating learning and memory in animals with complex behavior. The pioneering work of JZ Young described the morphological convergence of the VL with the mammalian hippocampus, cerebellum and the insect mushroom body. Studies in octopus and cuttlefish VL networks suggest evolutionary convergence into a universal organization of connectivity as a divergence-convergence ('fan-out fan-in') network with activity-dependent long-term plasticity mechanisms. Yet, these studies also show that the properties of the neurons, neurotransmitters, neuromodulators and mechanisms of long-term potentiation (LTP) induction and maintenance are highly variable among different species. This suggests that complex networks may have evolved independently multiple times and that even though memory and learning networks share similar organization and cellular processes, there are many molecular ways of constructing them.


Assuntos
Evolução Biológica , Cefalópodes/fisiologia , Aprendizagem/fisiologia , Memória/fisiologia , Animais , Encéfalo/anatomia & histologia , Encéfalo/fisiologia , Cefalópodes/anatomia & histologia , Sinapses/fisiologia
8.
Anim Reprod Sci ; 129(1-2): 50-5, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22005251

RESUMO

Intravaginal progesterone devices are used worldwide for estrus induction in goats. Reused devices are able to induce estrus; however, this can be a health risk within a flock. The objective was to compare new and previously used (and autoclaved) progesterone-releasing intravaginal devices for induction of estrus and ovulation in seasonally anestrous Toggenburg goats. Anestrous goats (n=42) received new intravaginal devices containing 0.3g progesterone (CONTROL), or similar devices previously used for either 6 (USED6) or 12d (USED12) and subsequently autoclaved. All goats received 5mg dinoprost at device insertion and 200 IU eCG 5d later, and all devices were removed after 6d. After device removal, estrus was monitored and females displaying signs of estrus were mated by fertile bucks. Transrectal ovarian ultrasonography was performed after device removal until detection of ovulation. Blood samples were collected for determination of plasma progesterone concentration at different times. There was no difference (P>0.05) among groups CONTROL, USED6 or USED12 for: estrus response (87, 100 or 100%, respectively); duration of estrus (32.3±2.3, 25.2±3.4 or 27.3±4.1h); ovulation rate (100, 88 or 100%); number of ovulations (1.5±0.2, 1.9±0.3 or 1.7±0.3); and pregnancy rate (60, 58 or 67%). Plasma progesterone (P4) concentrations were greater (P<0.05) in CONTROL than in USED6-treated and USED12-treated goats (7.2±1.2, 4.7±0.7 and 4.3±0.6 ng/mL, respectively) at 6h after device insertion; these differences were maintained until 4d after device insertion (3.4±0.4, 2.3±0.2, and 2.5±0.2 ng/mL). Overall, plasma progesterone concentrations were greater (P<0.05) in nulliparous than in lactating goats (3.1±0.8 compared to 2.4±0.6 ng/mL, respectively). In conclusion, autoclaved, previously used intravaginal progesterone-releasing devices resulted in significant lesser plasma progesterone concentrations than new devices, but were similarly effective in inducing estrus and ovulation in anestrous goats.


Assuntos
Sincronização do Estro/métodos , Cabras/fisiologia , Folículo Ovariano/fisiologia , Indução da Ovulação/métodos , Progesterona/farmacologia , Animais , Distribuição de Qui-Quadrado , Feminino , Masculino , Folículo Ovariano/diagnóstico por imagem , Indução da Ovulação/instrumentação , Gravidez , Progesterona/administração & dosagem , Progesterona/sangue , Ultrassonografia
9.
J Endocrinol Invest ; 32(3): 234-7, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19542740

RESUMO

Pheochromocytoma resection is often complicated by intra-operative hypertension and post-resection hypotension. Factors associated with these hemodynamic alterations are not well defined. The aim of this study was to analyse the clinical-laboratory features associated with hemodynamic parameters during pheochromocytoma resection. Twenty-seven patients submitted to tumor resection - either open (no.=18) or video laparoscopic - between 1978-2007 were included. Nineteen received pre-operative alpha-blockers. Intra-operative hemodynamic data analysed were: maximum and minimum mean arterial blood pressure (MABP), no. of severe hypertensive (systolic BP >200 mmHg) and hypotensive episodes (MABP <60 mmHg), maximum and minimum heart rate (HR), no. of episodes of tachycardia and bradycardia, need to receive iv intra-operative treatment for hypertension and hypotension and the volume of fluids administered during surgery. Patients were 39.4+/-14.4-yr-old, 66% women. Intra-operative hemodynamic parameters were not different in patients submitted to open or video laparoscopic resection. Maximum intraoperative HR and the percentage of patients with HR>100 beats/min were higher in patients without pre-operative alpha- blocker treatment (no.=8). Pre-operative urinary vanylmandelic acid was positively associated with intra-operative maximum MABP (r=0.535, p=0.047) and with maximum transoperative systolic BP (r=0.805, p=0.016). Pre-operative urinary catecholamine (Pearson correlation r=0.575, p=0.03) and vanylmandelic acid (Pearson correlation r=0.605, p=0.04) levels were associated with maximum intra- operative MABP, adjusted for the presence of pheochromocytoma symptoms, surgical approach and pre-operative alpha-blockers. In conclusion, the degree of pre-operative catecholamine secretion was the most important aspect of transoperative BP control.


Assuntos
Neoplasias das Glândulas Suprarrenais/diagnóstico , Neoplasias das Glândulas Suprarrenais/cirurgia , Catecolaminas/metabolismo , Hemodinâmica/fisiologia , Feocromocitoma/diagnóstico , Feocromocitoma/cirurgia , Neoplasias das Glândulas Suprarrenais/metabolismo , Neoplasias das Glândulas Suprarrenais/fisiopatologia , Antagonistas Adrenérgicos alfa/uso terapêutico , Adulto , Biomarcadores/metabolismo , Biomarcadores/urina , Pressão Sanguínea/fisiologia , Catecolaminas/urina , Feminino , Humanos , Período Intraoperatório , Masculino , Pessoa de Meia-Idade , Feocromocitoma/metabolismo , Feocromocitoma/fisiopatologia , Prognóstico , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
10.
Histol Histopathol ; 22(4): 409-16, 2007 04.
Artigo em Inglês | MEDLINE | ID: mdl-17290351

RESUMO

The RAS protooncogene has an important, although not yet established role in thyroid neoplasia. In this study, we evaluated the H-RAS mRNA and protein levels in human samples of nontoxic and toxic multinodular goiter samples, according to serum TSH levels. The mean of H-RAS mRNA levels in nodules of nontoxic nodular goiter were significantly increased compared to nonnodular tissue (1.49+/-1.21 vs. 0.94+/-0.81 AU, P=0.016). Nine of the 18 specimens (50%) of nontoxic multinodular goiter exhibited increased levels of H-RAS mRNA. The increased H-RAS mRNA levels were paralleled by inRAcreased H-Ras protein levels in about 90% of the cases. Interestingly, no differences were observed in H-RAS expression between nodules and adjacent nonnodular tissue in toxic nodular goiters (0.58+/-0.27 vs. 0.58+/-0.20 AU, P=0.88). None of the 10 samples from toxic multinodular goiters exhibited overexpression of H-RAS. The H-RAS expression was positively correlated with thyroglobulin expression (r2=0.51; P=0.04). In conclusion, we demonstrated increased levels of H-RAS mRNA and protein in samples of nontoxic multinodular goiter, indicating that it might be involved in goiter pathogenesis. In contrast, H-RAS overexpression was not detected in any of the samples of toxic multinodular goiter, suggesting different mechanisms for cell proliferation in nodular goiter according to thyroid status.


Assuntos
Expressão Gênica , Genes ras , Bócio Nodular/genética , Proteína Oncogênica p21(ras)/genética , Tireotoxicose/genética , Adulto , Idoso , Proliferação de Células , Análise Mutacional de DNA , Feminino , Bócio Nodular/metabolismo , Bócio Nodular/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Proteína Oncogênica p21(ras)/metabolismo , RNA Mensageiro/metabolismo , Estudos Retrospectivos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tireoglobulina/metabolismo , Tireotoxicose/metabolismo , Tireotoxicose/patologia , Tireotropina/metabolismo
11.
Diabet Med ; 22(9): 1167-72, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16108844

RESUMO

AIM: To investigate the association between angiotensin-converting enzyme gene I/D polymorphism and diabetic nephropathy (DN) in patients with Type 2 diabetes mellitus (DM) taking into consideration the known duration of DM. METHODS: Cross-sectional study with 982 patients categorized according to urinary albumin excretion (UAE) into normoalbuminuria (UAE < 20 microg/min or < 17 mg/l, 24-h timed urine or spot random sterile urine, respectively), incipient DN (UAE 20-199 microg/min or 17-174 mg/l) and overt DN (UAE > 200 microg/min or > 174 mg/l or dialysis). Patients were further grouped regarding presence of the D allele (DD/ID vs. II) and DM duration (< or = 10 years or > 10 years). RESULTS: Incipient DN was diagnosed in 17.3% (n = 170), and 20.7% (n = 203) had overt DN (macroalbuminuria, n = 129; dialysis, n = 74). Genotype distribution (DD/ID/II) was similar in patients with incipient (49/92/29) or overt DN (77/89/37) if compared with patients without DN (181/308/120, P = 0.172). In patients with DM < or = 10 years, having the D allele (DD/ID) resulted in an odds ratio (OR) of 2.66 (95% CI: 1.12-6.58, P = 0.015) for incipient DN, and 3.19 (95% CI: 1.18-9.30, P = 0.012) for overt DN. In patients with longer DM duration, the D allele did not increase the risk for incipient (OR 0.68, 95% CI 0.36-1.29, P = 0.206) or overt DN (OR 0.67, 95% CI 0.39-1.17, P = 0.138). CONCLUSION: The DD/ID genotypes were associated with incipient or overt DN in patients with DM < or = 10 years.


Assuntos
Diabetes Mellitus Tipo 2/genética , Nefropatias Diabéticas/genética , Peptidil Dipeptidase A/genética , Polimorfismo Genético/genética , Albuminúria/genética , Alelos , Estudos Transversais , Feminino , Frequência do Gene/genética , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
12.
J Mol Endocrinol ; 31(3): 541-50, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14664714

RESUMO

In the present study we show the expression profiles of both type 1 and type 2 iodothyronine deiodinases (D1 and D2) in a wide spectrum of mouse tIssues, and D2 regulation by thyroid status. A characteristic tIssue-specific expression for each isoform was observed. D2 transcripts were detected in most tIssues with variable levels of expression. The observed D2 mRNA tIssue distribution was similar to that described in rats and is in agreement with the view of different patterns of expression between rodents and humans. However, it is interesting to note that despite the low levels of D2 transcripts in mouse heart and testis in the euthyroid state, the induction of hypothyroidism caused a significant increase in D2 activity in these tIssues. Similar results were also obtained in adult rats. These results suggest a previously unrecognized role for type 2 deiodinase in controlling intracellular triiodothyronine levels in rodent heart and testis during states of thyroid hormone deficiency.


Assuntos
Iodeto Peroxidase/metabolismo , Miocárdio/metabolismo , Testículo/metabolismo , Distribuição Tecidual/efeitos dos fármacos , Animais , Masculino , Metimazol/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Ratos , Ratos Wistar , Tiroxina/sangue , Tri-Iodotironina/sangue , Tri-Iodotironina/metabolismo , Tri-Iodotironina/farmacologia , Iodotironina Desiodinase Tipo II
13.
Histol Histopathol ; 17(3): 739-45, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12168782

RESUMO

The progesterone-induced differentiation of endometrial tissue from proliferative into secretory and decidua seems to be modulated by locally produced hormones and cytokines. Transforming growth factor beta (TGFbeta). a cytokine produced by endometrial cells, has been shown to modulate endometrial cell proliferation in vitro. Our aim was to evaluate the effects of medroxyprogesterone acetate (MPA) and the influence of menstrual cycle on the expression of TGFbeta1 and TGFbeta3 in human endometrium in vivo. In a double-blind, placebo-controlled trial, 46 healthy women with regular menstrual cycles received either MPA (10 mg/day) or placebo during 10 days. Endometrial and blood samples were collected 8-12 hours after the last MPA or placebo administration. Patients were classified into three groups according to biopsy dating and treatment: proliferative [tissue]/placebo, secretory [tissue]/placebo and secretory [tissue]/MPA. The immunohistochemical distribution of TGFbeta1 and TGFbeta1 mRNA was similar in all groups. Immunoreactive TGFbeta3 was present in the epithelium in 9.1% of proliferative samples, in 41.2% of secretory/placebo samples and in 87.5% of secretory/MPA samples (p=0.001). In the stroma, the frequency of TGFbeta3 staining was markedly increased after treatment with MPA (62.5%) compared to placebo (proliferative: 9.1%; secretory: 5.9%; p=0.005). The levels of TGFbeta3 mRNA increased during the secretory phase and were higher in the MPA-treated group, being directly correlated with morphological endometrial differentiation. It is concluded that MPA administration to healthy women increased TGFbeta3 but did not change TGFbeta1 gene and protein expression in the endometrium. This finding suggests that TGFbeta3 may be a local factor mediating progesterone- and progestogen-induced endometrial differentiation.


Assuntos
Endométrio/metabolismo , Progestinas/biossíntese , Fator de Crescimento Transformador beta/biossíntese , Adulto , Diferenciação Celular , DNA Complementar/metabolismo , Endométrio/patologia , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Imuno-Histoquímica , Acetato de Medroxiprogesterona/farmacologia , Ciclo Menstrual , Congêneres da Progesterona/farmacologia , Progestinas/metabolismo , Isoformas de Proteínas , RNA/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo , Fator de Crescimento Transformador beta1 , Fator de Crescimento Transformador beta3
14.
J Clin Endocrinol Metab ; 86(8): 3488-93, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11502768

RESUMO

The effect of antithyroid drugs on the efficacy of radioiodine (131I) treatment is still controversial. This study evaluated the effect of methimazole pretreatment on the efficacy of 131I therapy in Graves' hyperthyroidism. Sixty-one untreated patients were randomly assigned to receive 131I alone (32 patients) or 131I plus pretreatment with methimazole (30 mg/d; 29 patients). 131I was administered 4 d after drug discontinuation. The calculated 131I dose was 200 microCi/g thyroid tissue as estimated by ultrasound, corrected by 24-h radioiodine uptake. Serum TSH, T4, and free T4 were measured 4 d before 131I therapy, on the day of treatment, and then monthly for 1 yr. Considering cure as euthyroidism or hypothyroidism, based on free T4 measurement, approximately 80% of patients from both groups were cured 3 months after beginning 131I treatment. After 1 yr the groups were similar in terms of persistent hyperthyroidism (15.6% vs. 13.8%), euthyroidism (28.1% vs. 31.0%), or hypothyroidism (56.3% vs. 55.2%). Relapsed patients presented larger thyroid volume (P = 0.002), higher 24-h radioiodine uptake (P = 0.022), and T3 levels (P = 0.002). Multiple logistic regression analysis identified T3 values as an independent predictor of therapy failure. In conclusion, pretreatment with methimazole had no effect on either the time required for cure or the 1-yr success rate of 131I therapy.


Assuntos
Antitireóideos/uso terapêutico , Doença de Graves/tratamento farmacológico , Doença de Graves/radioterapia , Radioisótopos do Iodo/uso terapêutico , Metimazol/uso terapêutico , Adulto , Terapia Combinada , Feminino , Seguimentos , Humanos , Hipertireoidismo/tratamento farmacológico , Hipertireoidismo/radioterapia , Masculino , Estudos Prospectivos , Dosagem Radioterapêutica , Análise de Regressão , Glândula Tireoide/anatomia & histologia , Glândula Tireoide/efeitos da radiação , Tiroxina/sangue , Fatores de Tempo , Tri-Iodotironina/sangue
15.
J Clin Microbiol ; 38(10): 3890-1, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11015430

RESUMO

Fungal infection of the thyroid is rare. Most reported cases have involved Aspergillus, Coccidioides, and Candida species in the setting of disseminated disease. Infection of the thyroid with Histoplasma capsulatum is rarely reported as part of disseminated disease, even in geographic areas where histoplasmosis is endemic. We report a 52-year-old woman with a previous Hashimoto's disease and non-Hodgkin's lymphoma in which a diffuse enlarged thyroid gland with a large nodule was the only apparent locus of histoplasmosis. Fine-needle aspiration of the thyroid was an important diagnostic tool in establishing the diagnosis of histoplasmosis of the thyroid. The patient was initially treated with itraconazole (400 mg/day) for the fungal infection and six cycles of chemotherapy for the lymphoma. At a 6-month follow-up examination, the patient was doing well on suppressive therapy of itraconazole (200 mg/day), with no symptoms and with regression of the thyroid nodule and cervical adenopathy.


Assuntos
Histoplasmose/patologia , Doenças da Glândula Tireoide/patologia , Glândula Tireoide/microbiologia , Antifúngicos/uso terapêutico , Feminino , Histoplasmose/complicações , Histoplasmose/tratamento farmacológico , Humanos , Itraconazol/uso terapêutico , Linfoma não Hodgkin/complicações , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/patologia , Macrófagos/microbiologia , Macrófagos/patologia , Pessoa de Meia-Idade , Doenças da Glândula Tireoide/complicações , Doenças da Glândula Tireoide/microbiologia , Glândula Tireoide/patologia , Tireoidite Autoimune/complicações , Resultado do Tratamento
16.
J Clin Endocrinol Metab ; 84(11): 4012-6, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10566642

RESUMO

Radioiodine (131I) is the preferred definitive treatment for Graves' hyperthyroidism. Pretreatment with antithyroid drugs is often used to avoid thyroid hormone discharge after 131I ablation. However, this may represent an unnecessary increase in risk and costs. Fifty-one patients with Graves' disease were randomly assigned to receive 131I alone (28 patients) or 131I plus pretreatment with methimazole (30 mg/day; 23 patients). Methimazole was interrupted 4 days before 131I therapy. Serum T4, free T4 (FT4), and T3 were measured on days -4 and -1, on the day of treatment, and on days 2, 5, 7, 14, 20, and 30. In patients receiving 131I alone, mean serum T4 levels did not change after therapy. Mean serum FT4 and T3 levels decreased significantly 5 days after 131I administration (15% and 18%, respectively). Serum T3 reached its lowest level on day 30 (38%). With pretreatment, mean serum T4, FT4, and T3 levels increased (38%, 39%, and 70%, respectively) after methimazole discontinuation and before 131I administration. After 131I, serum T4 levels peaked on day 7 (23% vs. treatment day; 70% vs. baseline); FT4 levels peaked on day 14 (53% vs. treatment day; 107% vs. baseline). The serum T3 concentration increased 9% on day 2 (85% vs. baseline) and decreased from day 14 (15%) to day 30 (21%). We conclude that interruption of antithyroid drugs causes a short term increase in serum thyroid hormone levels in patients with Graves' hyperthyroidism receiving 131I. Thyroid hormone levels stabilize or decrease during the first 30 days after 131I therapy.


Assuntos
Antitireóideos/uso terapêutico , Doença de Graves/radioterapia , Metimazol/uso terapêutico , Tiroxina/sangue , Tri-Iodotironina/sangue , Adulto , Antitireóideos/administração & dosagem , Feminino , Doença de Graves/tratamento farmacológico , Humanos , Radioisótopos do Iodo/uso terapêutico , Masculino , Metimazol/administração & dosagem
17.
Braz. j. med. biol. res ; 32(9): 1133-43, Sept. 1999. tab
Artigo em Inglês | LILACS | ID: lil-241609

RESUMO

The main objective of the present study was to evaluate the diagnostic value (clinical application) of brain measures and cognitive function. Alzheimer and multiinfarct patients (N = 30) and normal subjects over the age of 50 (N = 40) were submitted to a medical, neurological and cognitive investigation. The cognitive tests applied were Mini-Mental, word span, digit span, logical memory, spatial recognition span, Boston naming test, praxis, and calculation tests. The brain ratios calculated were the ventricle-brain, bifrontal, bicaudate, third ventricle, and suprasellar cistern measures. These data were obtained from a brain computer tomography scan, and the cutoff values from receiver operating characteristic curves. We analyzed the diagnostic parameters provided by these ratios and compared them to those obtained by cognitive evaluation. The sensitivity and specificity of cognitive tests were higher than brain measures, although dementia patients presented higher ratios, showing poorer cognitive performances than normal individuals. Normal controls over the age of 70 presented higher measures than younger groups, but similar cognitive performance. We found diffuse losses of tissue from the central nervous system related to distribution of cerebrospinal fluid in dementia patients. The likelihood of case identification by functional impairment was higher than when changes of the structure of the central nervous system were used. Cognitive evaluation still seems to be the best method to screen individuals from the community, especially for developing countries, where the cost of brain imaging precludes its use for screening and initial assessment of dementia


Assuntos
Pessoa de Meia-Idade , Feminino , Humanos , Envelhecimento/fisiologia , Encéfalo , Cognição/fisiologia , Demência/diagnóstico , Fatores Etários , Idoso de 80 Anos ou mais , Doença de Alzheimer/diagnóstico , Análise de Variância , Líquido Cefalorraquidiano , Demência Vascular/diagnóstico , Demência , Escolaridade , Nível de Saúde , Imageamento por Ressonância Magnética , Sensibilidade e Especificidade , Classe Social
18.
Braz J Med Biol Res ; 32(9): 1133-43, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10464391

RESUMO

The main objective of the present study was to evaluate the diagnostic value (clinical application) of brain measures and cognitive function. Alzheimer and multi-infarct patients (N = 30) and normal subjects over the age of 50 (N = 40) were submitted to a medical, neurological and cognitive investigation. The cognitive tests applied were Mini-Mental, word span, digit span, logical memory, spatial recognition span, Boston naming test, praxis, and calculation tests. The brain ratios calculated were the ventricle-brain, bifrontal, bicaudate, third ventricle, and suprasellar cistern measures. These data were obtained from a brain computer tomography scan, and the cutoff values from receiver operating characteristic curves. We analyzed the diagnostic parameters provided by these ratios and compared them to those obtained by cognitive evaluation. The sensitivity and specificity of cognitive tests were higher than brain measures, although dementia patients presented higher ratios, showing poorer cognitive performances than normal individuals. Normal controls over the age of 70 presented higher measures than younger groups, but similar cognitive performance. We found diffuse losses of tissue from the central nervous system related to distribution of cerebrospinal fluid in dementia patients. The likelihood of case identification by functional impairment was higher than when changes of the structure of the central nervous system were used. Cognitive evaluation still seems to be the best method to screen individuals from the community, especially for developing countries, where the cost of brain imaging precludes its use for screening and initial assessment of dementia.


Assuntos
Envelhecimento/fisiologia , Encéfalo/diagnóstico por imagem , Cognição/fisiologia , Demência/diagnóstico , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/diagnóstico , Análise de Variância , Demência/diagnóstico por imagem , Demência Vascular/diagnóstico , Escolaridade , Feminino , Nível de Saúde , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Radiografia , Sensibilidade e Especificidade , Classe Social
19.
Fertil Steril ; 71(6): 1125-32, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10360922

RESUMO

OBJECTIVE: To evaluate the influence of the menstrual cycle and the effects of medroxyprogesterone acetate (MPA) on the expression of the protooncogene c-fos and of prolactin (PRL) in the human endometrium in vivo. DESIGN: Double-blind, placebo-controlled trial. SETTING: Healthy volunteers in an academic research environment. PATIENT(S): Regularly cycling women who were not taking hormonal medication. INTERVENTION(S): Medroxyprogesterone acetate (10 mg/d) or placebo was given for 10 days. Endometrial and blood samples were collected 8-12 hours after the last dose. MAIN OUTCOME MEASURE(S): Immunohistochemical localization of PRL and c-fos in the endometrium, PRL and c-fos messenger RNA levels in the endometrium, and E2 and progesterone levels in the serum. RESULT(S): Immunoreactive c-fos was concentrated in the nucleus of stromal cells and was observed in a higher proportion of proliferative endometrial specimens compared with secretory specimens from placebo or MPA-treated patients. The levels of c-fos messenger RNA were greatly reduced in the secretory endometrium regardless of treatment with placebo or MPA, compared with the proliferative endometrium. The c-fos gene expression correlated positively with the serum E2 levels (r = 0.56) and inversely with the progesterone/E2 ratio (r = -0.56). The endometrial PRL gene expression (messenger RNA and protein) was rare in the proliferative samples, increased from the early to the mid and late secretory samples, and was increased markedly after treatment with MPA compared with placebo. CONCLUSION(S): The differentiation of secretory endometrium is accompanied by decreased c-fos and increased PRL gene expression. The inhibition of c-fos gene expression may contribute to the antiproliferative effect of progestins on the endometrium.


Assuntos
Endométrio/metabolismo , Expressão Gênica/efeitos dos fármacos , Genes fos/genética , Acetato de Medroxiprogesterona/farmacologia , Congêneres da Progesterona/farmacologia , Prolactina/genética , Adulto , Biópsia , Método Duplo-Cego , Endométrio/química , Estradiol/sangue , Feminino , Humanos , Imuno-Histoquímica , Placebos , Progesterona/sangue , Prolactina/análise , Proteínas Proto-Oncogênicas c-fos/análise , RNA Mensageiro/análise
20.
Thyroid ; 6(4): 325-8, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8875755

RESUMO

Transient expression assays using a luciferase (LUC) reporter gene are often used in studies of positive and negative thyroid hormone response elements (TREs) or of wild-type and mutated thyroid hormone receptors (TRs). However, unliganded TR (the beta isoform > than the alpha) increases LUC expression from 2 different TK-LUC vectors in several cell types, especially JEG-3 cells, and 3,5,3'-triiodothyronine (T3) reduces that expression by as much as 80% in a TR-dependent manner. The TR effects require an intact TR DNA-binding domain and the results suggest that there may be a negative TRE in the LUC cDNA. We conclude that great care must be used in the interpretation of studies of thyroid hormone action using LUC expression plasmids especially when these are performed in JEG-3 cells.


Assuntos
Genes Reporter/fisiologia , Luciferases/biossíntese , Receptores dos Hormônios Tireóideos/biossíntese , Animais , Linhagem Celular , Humanos , Luciferases/genética , Camundongos , Mutação , Plasmídeos , Ratos , Receptores dos Hormônios Tireóideos/genética , Transfecção , Tri-Iodotironina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA